RxDoctor Payments Data

Sharonda Basby

Family · Warner Robins, GANPI 1669875225

Payments from drug & device makers

$1,836in general payments, 2019–2025

Across 88 payments — averaging $20.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$357
  • Otsuka America Pharmaceutical, Inc.$170
  • Boston Scientific$169
  • AbbVie$129
  • Sumitomo Pharma America, Inc.$98
  • Lundbeck LLC$91
  • plus $821 from 21 others

What the payments were for

  • Food & beverage$1,836100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,836 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$29,769
Albuterol Sulfate HfaAlbuterol Sulfate25$752
Gabapentin16$182
Acetaminophen-CodeineAcetaminophen With Codeine11$172
Lisinopril20$168
Quetiapine Fumarate14$140
Tizanidine Hcl26$134
Doxycycline Hyclate13$127
Losartan Potassium19$123
Methylprednisolone15$109
Ondansetron Hcl14$95
Amlodipine Besylate20$86
Atorvastatin Calcium11$85
Furosemide11$78
Fluconazole12$76

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$357$29,76918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Warner Robins

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →